We are pleased to announce being awarded a CIHR project grant. Our proposal (funded for 4 years; $631,124) is entitled, “Quantitative PSMA Targeted Imaging of Prostate Cancer Patients”. We aim to improve assessment of disease for prostate cancer patients in the context of our ongoing clinical trials involving prostate-specific membrane antigen (PSMA) radioligand therapy (also known as radiopharmaceutical therapy). We will pursue advanced PSMA PET data acquisition (particularly dynamic whole-body imaging), as well as improved image reconstruction and enhancement. Our efforts will also involve automated deep-learning based segmentation of PET images, as well as predictive modeling of prostate cancer using radiomics and machine learning methods.
CIHR Project Grant Awarded for Theranostic Imaging of Prostate Cancer
Categories
Share This
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.